statements relating to events and trends relevant to us, including with respect to our financial condition, results of operations, short- and long-term business operations, objectives, and financial needs
Current investigations include: Preserving lean tissue during fat mass reduction with GLP-1based drugs Use in sarcopenia and other muscle-wasting disorders Metabolic disease contexts, including obesity Evaluation in triplet therapy or other triplet combination strategies You cannot access it outside controlled clinical trials
Drinking between meals rather than during meals can help manage the feeling of fullness that GLP-1 medications produce
The defendants also refer to these FDA approvals to mislead customers to believe that these compounded products have cleared regulatory scrutiny, Lilly contends
conversely, other potential dietary supplements able to sustain muscle metabolism and recovery from exercise have never been taken into consideration
The most notable of these potential complications would be insulin resistance and severe cardiovascular complications [R, R]